AndreaBozzo/ceres-open-data-index huggingface dataset:
Managed Care Institutional Provider Network Data: March 31, 2017

The primary purpose for the Provider Network Data System is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of health plans in New York State. Beginning in 2017, the PNDS includes Medicaid Managed Care (MMC), HIV Special Need Plans (SNP), Health and Recovery Plans (HARP), Child Health Plus (CHP), Programs of All-Inclusive Care for the Elderly (PACE), Non-PACE Managed Long-Term Care (MLTC) plans, Qualified Health Plans (QHP), Essential Plans (EP), and commercial plans (commercial plan reporting will be incomplete until Q2 2017). This dataset reflects institutional provider data. Provider Network Data System information is self-reported by health plans. The PNDS data dictionary can be found at http://www.health.ny.gov/health_care/managed_care/docs/dictionary.pdf. To use the NYS Provider & Health Plan Look-Up Tool, click on the following link, https://pndslookup.health.ny.gov/.
Compound 526493: 5-Chloro-2'-fluoro-2-diethyaminoethylaminobenzophenone

Chemical compound data from PubChem database. IUPAC Name: [5-chloro-2-[2-(diethylamino)ethylamino]phenyl]-(2-fluorophenyl)methanone. Molecular Formula: C19H22ClFN2O. Molecular Weight: 348.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401669-T1: [Translated] LINEAR ULTRASONIC MOTOR

The invention relates to a linear ultrasound piezoelectric motor comprising a mobile element that is in frictional contact with a plate-like rectangular resonance plate, wherein the frictional surface is embodied by means of at least one of the longitudinal narrow sides of the resonance plate, and electrodes for producing acoustic vibrations which are arranged on the longitudinal wide sides of the resonance plate. According to the invention, the generator for producing acoustic vibrations is asymmetrically arranged in relation to a plane which symmetrically cross-cuts the resonance plate, and comprises two opposing electrodes generating a stationary asymmetrical space wave when excited.
The plasma membrane carbonic anhydrase in murine hepatocytes identified as isozyme XIV

Background
          Biochemical and histochemical studies have both previously indicated plasma membrane-associated carbonic anhydrase (CA) activity in hepatocytes which has been assumed to be CA IV. However, immunohistochemical data did not support this assignment. Recent northern blotting results indicated the presence of mRNA for the most recently discovered membrane-bound CA isozyme, CA XIV, in the liver. The present study was designed to examine whether CA XIV could contribute to the CA activity described in the hepatocytes.
        
        
          Methods
          Tissue samples from mouse liver were subjected to immunohistochemical staining using the antibodies raised against recombinant mouse CA XIV and CA IV. RT-PCR and western blotting were also performed for CA XIV.
        
        
          Results
          A strong immunofluorescent signal was observed in the plasma membrane of mouse hepatocytes. Although CA XIV was expressed on both the apical and basolateral surfaces, the staining was more prominent at the apical (canalicular) membrane domain. The expression of CA XIV in the liver was confirmed by RT-PCR and western blotting.
        
        
          Conclusions
          The presence of CA XIV in the hepatocyte plasma membrane places this novel enzyme at a strategic site to control pH regulation and ion transport between the hepatocytes, sinusoids and bile canaliculi.
National Youth Survey US: Wave VI (NYS-1983)

<p>Youth data for the sixth wave of the National Youth Survey<br />
are contained in this collection. This research project, which was<br />
designed to gain a better understanding of both conventional and<br />
deviant types of behavior by youths, involved collecting information<br />
from a representative sample of young people in the United States. The<br />
first wave of this survey was conducted in 1976, the<br />
second wave in 1977, the third wave in 1978,<br />
the fourth wave in 1979, and the fifth wave in 1980. For this wave, youths and young adults were interviewed in early<br />
1984 about events and behavior occurring in calendar year 1983, when<br />
they were 17 to 26 years of age. Data are available on the demographic<br />
and socioeconomic status of respondents, disruptive events for parents,<br />
neighborhood problems, employment, children, aspirations and current<br />
successes, normlessness, labeling by parents, perceived disapproval by<br />
parents, peers, co-workers, and partner, attitudes toward deviance,<br />
exposure to delinquent peers, self-reported delinquency, drug and<br />
alcohol use, victimization, pregnancy, depression, use of outpatient<br />
services, spouse violence by respondent and partner, and sexual<br />
activity.This study has 1 Data Set.</p>
Patent AT-E401533-T1: [Translated] CONTROL OF A CYCLONE BURNER

A method of operating a combustion process in a cyclone burner, after start-up thereof, is provided. A fuel and a combustion gas is fed into a combustion chamber of the cyclone burner. The velocity of the combustion gas is kept between a lower and an upper limiting gas velocity. The stoichiometric condition (sub- or over-stoichiometric) is maintained by controlling the amount of fed oxygen to the amount of fed fuel. A shift is made to the other stoichiometric condition while preventing the combustion gas from obtaining a velocity outside the range defined by the lower and upper limiting gas velocity.
Patent AT-E399527-T1: [Translated] DYE CONTAINING A TERTIARY PARAPHENYLENEDIAMINE SUBSTITUTED WITH A PYRROLIDINE AND A SURFACTANT; METHODS AND USES

A composition (A) for dyeing keratin fibers comprises a dyeing medium containing at least one pyrrolidine ring-containing tertiary cationic p-phenylene diamine (I) and at least one surfactant (II) selected from (a) oxyalkylenated ether carboxylic acids and their salts and (b) mono- or poly-glycerolated nonionic surfactants.  Independent claims are included for: (a)  an oxidation dyeing process for keratin fibers, involving applying (A) to the fibers in presence of an oxidizing agent (B); and  (b) a multi-compartment device (dyeing kit), having one compartment containing (A) and another compartment containing (B).
Patent AT-E400814-T1: [Translated] PIN1 AS A STAGE MARKER OF AGGRESSIVITY AND/OR METASTASIZATION ABNORMAL CELL GROWTH

Methods for the use of Pin1 as a marker of abnormal cell growth are disclosed. In one embodiment, the method includes detecting a level of Pin1 to stage an abnormal cell growth, such as breast or prostate cancer. In another embodiment, the method includes evaluating the efficacy of a treatment of an abnormal cell growth, such as cancer, by monitoring the levels of Pin1. In another embodiment, the method includes evaluating the extent of metastasis of abnormal cell growth, such as cancer. The levels of Pin1 can be protein levels or nucleic acid levels.
NNDSS - TABLE 1P. Hemolytic uremic syndrome post-diarrheal to Hepatitis B, acute

NNDSS - TABLE 1P. Hemolytic uremic syndrome post-diarrheal to Hepatitis B, acute - 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Data from California published in week 29 for years 2019 and 2020 were incomplete when originally published on July 24, 2020. On August 4, 2020, incomplete case counts were replaced with a "U" indicating case counts are not available for specified time period. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Compound 530258: 1,3,5-Tris(bromomethyl)benzene

Chemical compound data from PubChem database. IUPAC Name: 1,3,5-tris(bromomethyl)benzene. Molecular Formula: C9H9Br3. Molecular Weight: 356.88. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2015 CMHS Uniform Reporting System (URS) Table for Ohio

2015 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Ohio.  The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 525043: D-Mannitol, 1,2,3,4,5,6-hexakis-O-(trimethylsilyl)-

Chemical compound data from PubChem database. IUPAC Name: trimethyl-[(2S,3S,4S,5S)-1,2,4,5,6-pentakis(trimethylsilyloxy)hexan-3-yl]oxysilane. Molecular Formula: C24H62O6Si6. Molecular Weight: 615.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525657: p-Bromobenzylidene-(3-methylphenyl)-amine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-bromophenyl)-N-(3-methylphenyl)methanimine. Molecular Formula: C14H12BrN. Molecular Weight: 274.15. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399556-T1: [Translated] TRANSFUSION PREPARATION FOR PERIPHERAL INTRAVENOUS ADMINISTRATION AND METHOD FOR STABILIZING VITAMIN B1

The infusion preparation for peripheral parenteral administration comprises an infusion (A) containing glucose with 80 to 200 g/L concentration, and an infusion (B) containing amino acid with 50 to 150 g/L concentration. The infusion (A) and the infusion (B) are separately put into a vessel that is divided with an openable partition means. The infusion (A) does not contain sulfite, has titratable acidity of 1 or less, contains vitamin B1 and is adjusted to pH 3 to 5. The infusion (B) is adjusted to pH 6.5 to 8. After mixing the both infusions, the mixture has pH 6 to 7.5 and titratable acidity of 5 to 10.
Compound 530132: 7-Hydroxyquinoline, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl(quinolin-7-yloxy)silane. Molecular Formula: C12H15NOSi. Molecular Weight: 217.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526974: para-alpha-Hydroxymononitrodiphenylacetic acid, methyl ester

Chemical compound data from PubChem database. IUPAC Name: methyl 2-hydroxy-2-(4-nitrophenyl)-2-phenylacetate. Molecular Formula: C15H13NO5. Molecular Weight: 287.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399788-T1: [Translated] METHOD FOR PRODUCING 9,10-DIHYDRO-9-OXA-10-ORGANYL-PHOSPHAPHENANTHRENE-10-OXIDE AND DERIVATIVES THEREOF

Preparation of 9,10-dihydro-9-oxa-10-organylphosphaphenanthrene-10-oxide comprises reacting 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide with a mono- or polyhydric alcohol and an ortho ester to form a first intermediate. The first intermediate is reacted with another mono- or polyhydric alcohol to form a second intermediate which is converted to the product using an alkylation agent. An independent claim is also included for a process for the preparation of a natural product or plastic having flame-retardant properties, comprising the inventive preparation process, and introducing the second intermediate product into the natural product or plastic.
Patent AT-E40085-T1: [Translated] FLEXIBLE AND WATERPROOF CONTAINER FOR TRANSPORTING BULK MATERIALS.

1. Impervious container (1) for packaging powdered products or very fine granules, comprising an external envelope made from two sheets of web (2) fixed together both laterally and transversely by seams (3, 4, 5, 6) and an internal envelope (8) cemented to the two sheets of web and welded at the base, the said external envelope having at least one longitudinal slit (lateral opening 7) near the top through which a mouth (tubular element 10) of the internal envelope can be withdrawn, the base of the said external envelope being stitched through one of the transverse seams (3, 4) and being gathered to form a twist at the bottom (15) which is tied by a cord (16) while its mouth is gathered and tied by one or more cords or by a band of web (17) in order to be suspended from a hook (23), characterized in that the longitudinal slit is made by interrupting one (5) of the lateral seams (5, 6) to provide a lateral opening (7), the mouth of the internal envelope (8) is made in the form of a tubular element (10) by producing a longitudinal slit (11) starting at the top and welding the longitudinal part (13) corresponding to the length of the two sides of the edges of the slit as well as the upper transverse part (12) running from the said slit to the farther end of the lateral opening, the said tubular element (10) being drawn through the lateral opening to form an internal neck for filling (18), which is sealed after filling by means of a knot (22) before being pushed inside the container (1) again.
Compound 525112: 2,3-Dichloropropyl octanoate

Chemical compound data from PubChem database. IUPAC Name: 2,3-dichloropropyl octanoate. Molecular Formula: C11H20Cl2O2. Molecular Weight: 255.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525983: 2-Methyl-4-nonylbenzo[b]thiophene

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-4-nonyl-1-benzothiophene. Molecular Formula: C18H26S. Molecular Weight: 274.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
CDC STATE System E-Cigarette Legislation - Preemption Summary

1995-2024. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. E-Cigarette Legislation – Preemption. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include information related to summary state preemption of more stringent or differing local laws on smokefree indoor air, youth access and licensure that are applicable to e-cigarettes.
ONC Regional Extension Centers (REC) Key Performance Indicators (KPIs) by Grantee

The ONC Regional Extension Centers (REC) Program provides assistance to health care providers to adopt and meaningfully use certified EHR technology. The program, funded through the American Recovery and Reinvestment Act (ARRA) or The Recovery Act, provides grants to organizations, Regional Extension Centers, that assist providers directly in the organization's region. There are 62 unique RECs across the United States. This data set provides federal funding granted to each REC, each REC's program goals, and various metrics on the total providers that have signed up with an REC for assistance, gone live on an EHR, and demonstrated meaningful use of certified EHR technology. This data set is an artifact of ONC's performance measurement and data analysis during the life of ARRA. RECs continue to assist providers to go live and demonstrate meaningful use of EHRs. See ONC's other REC data to track these metrics at the state and county level.
National Death Index

<p>The National Death Index (NDI) is a centralized database of death record information on file in state vital statistics offices. Working with these state offices, the National Center for Health Statistics (NCHS) established the NDI as a resource to aid epidemiologists and other health and medical investigators with their mortality ascertainment activities.</p>
<p>Assists investigators in determining whether persons in their studies have died and, if so, provide the names of the states in which those deaths occurred, the dates of death, and the corresponding death certificate numbers. Investigators can then make arrangements with the appropriate state offices to obtain copies of death certificates or specific statistical information such as manner of death or educational level. Cause of death codes may also be obtained using the NDI Plus service.</p>
<p>Records from 1979 through 2011 are currently available and contain a standard set of identifying information on each death. Death records are added to the NDI file annually, approximately 12 months after the end of a particular calendar year. 2012 should be available summer 2014. Early Release Program for 2013 is now available.</p>
<p>The NDI service is available to investigators solely for statistical purposes in medical and health research. The service is not accessible to organizations or the general public for legal, administrative, or genealogy purposes.</p>
Prevention: Delivering Services Through Education

This Child Welfare Information Gateway Podcast is available on Apple Podcasts
  
  

, GooglePlay
  
  

, Spotify
  
  

, Stitcher
  
  

, SoundCloud
  
  

, and the Child Welfare Information Gateway
  
  

 website. Subscribe to receive new episodes as they are released.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E401305-T1: [Translated] SYNTHESIS OF HETEROCYCLIC COMPOUNDS WHICH CONTAIN FIVE OR SIX RINGS

The following are claimed: (A) anthracycline compounds of formula Q-O-R-P (I) Q = a group of formula (i):R = H (sic) or C(O)-(CH2)n-C(O);n = 0-7;R' = NH2; or an aromatic or hydrogenated 5 or 6 membered heterocycle having at least one ring nitrogen, optionally having a butadiene moiety bonded to adjacent carbon atoms to form a bicyclic system;P = H or a peptide; Provided that: (a) where R' is NH2, then R and P are other than H; and (b) where R and P are H, then R' is other than NH2. (B) Conversion of the nitrogen of a primary amino group of an ~a,~b- or ~a,~c-hydroxy primary amine into the nitrogen of a monounsaturated nitrogen-containing heterocyclic compound having 5-6 ring atoms, comprising: (a) treating the hydroxy amine with an excess of a haloaldehyde having an aldehyde carbon, a halo-bearing carbon and having 2 or 3 moieties between the aldehyde carbon and the halo-bearing carbon selected from CH2, CH2CH2 and OCH2; (b) adding an excess (relative to the hydroxyamine) of an organic base; (c) neutralising the base with a weak acid; and (d) treating with a dilute aqueous acid. X' = halo; Y = CH2, OCH2 or CH2-CH2; Z is absent or is CH2.
Compound 528427: Flavanone, 5,7-dihydroxy-4'-methoxy, bis-TMS

Chemical compound data from PubChem database. IUPAC Name: 2-(4-methoxyphenyl)-5,7-bis(trimethylsilyloxy)-2,3-dihydrochromen-4-one. Molecular Formula: C22H30O5Si2. Molecular Weight: 430.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Oral health behavior patterns among Tanzanian university students: a repeat cross-sectional survey

Purpose
          This study examines oral health behavioral trends and the development of sociodemographic differences in oral health behaviors among Tanzanian students between 1999 and 2000.
        
        
          Methods
          The population targeted was students attending the Muhimbili University College of Health Sciences (MUCHS) at the University of Dar es Salaam (UDSM), Dar es Salaam, Tanzania. Cross-sectional surveys were conducted and a total of 635 and 981 students, respectively, completed questionnaires in 1999 and 2001.
        
        
          Results
          Cross-tabulation analyses revealed that in 1999, the rates of abstinence from tobacco use, and of soft drink consumption, regular dental checkups, and intake of chocolate/candy were 84%, 51%, 48%, and 12%, respectively, among students of urban origin and 83%, 29%, 37%, and 5% among their rural counterparts. The corresponding rates in 2001 were 87%, 56%, 50%, and 9% among urban students and 84%, 44%, 38%, and 4% among rural ones. Multiple logistic regression analyses controlling for sex, age, place of origin, educational level, year of survey, and their interaction terms revealed a significant increase in the rate of soft drink consumption, implementation of oral hygiene measures, and abstinence from tobacco use between 1999 and 2001. Social inequalities observed in 1999, with urban students being more likely than their rural counterparts to take soft drinks and go for regular dental checkups, had leveled off by 2001.
        
        
          Conclusion
          This study provides initial evidence of oral health behavioral trends, that may be utilized in the planning of preventive programs among university students in Tanzania.